Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

RTTNews | 1075 일 전
Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

(RTTNews) - Biopharmaceutical company Xeris Biopharma Holdings, Inc. (XERS) announced Wednesday that it has entered into a research collaboration and option agreement with Horizon Therapeutics plc (HZNP).

Under the terms of the agreement, Xeris will use its proprietary formulation technology platform, XeriJect, to develop an ultra-concentrated, ready-to-use, subcutaneous injection of teprotumumab and Horizon will have an option to license the Xeris technology.

Teprotumumab is the first and only medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of Thyroid Eye Disease (TED) - a serious, progressive and potentially vision-threatening rare autoimmune disease. Teprotumumab-trbw is known as TEPEZZA in the United States.

Xeris will receive an upfront payment, and may be entitled to receive development milestones, regulatory milestones, and sales-based milestones, as well as royalties based on future sales if the commercial license option is exercised. However, specific financial terms of the agreement were not disclosed.

For More Such Health News, visit rttnews.com

read more
European Shares Set For Mixed Open

European Shares Set For Mixed Open

European stocks are seen opening broadly higher on Monday, though French markets may drift lower after the National Assembly voted down dual proposals to tax the ultra-wealthy, dealing a blow to left-wing lawmakers who had made fiscal reform their condition for passing the budget.
RTTNews | 1 시간 47 분 전
Sensex, Nifty Struggle For Direction In Early Trade

Sensex, Nifty Struggle For Direction In Early Trade

Indian shares struggled for direction on Monday ahead of a big week for earnings, with around 200 prominent companies scheduled to report their quarterly earnings results.
RTTNews | 2 시간 48 분 전
Australian Market Slashes Early Losses In Mid-market

Australian Market Slashes Early Losses In Mid-market

The Australian stock market is slashing its early losses in mid-market trading on Monday, but extending the losses in the previous four sessions, despite the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is staying below the 8,850 level, with weakness in materials stocks partially offset by gains in energy, financial and technology stocks.
RTTNews | 3 시간 59 분 전
Asian Markets Track Wall Street Higher

Asian Markets Track Wall Street Higher

Asian stock markets are trading mostly higher on Monday, following the broadly positive cues from Wall Street on Friday, as a temporary tariff truce materialized between the U.S. and China wherein China agreed to buy more U.S. energy. This gave fresh optimism about smooth trade relations between the two major oil consumers of the world. Asian markets closed mixed on Friday.
RTTNews | 4 시간 6 분 전